Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist

Tranilast inhibits cell proliferation and migration and promotes apoptosis in murine breast cancer

(2010) Venkateswaran Subramaniam et al.   ANTI-CANCER DRUGS

The aryl hydrocarbon receptor: Regulation of hematopoiesis and involvement in the progression of blood diseases

(2010) Fanny L. Casado et al.   BLOOD CELLS MOLECULES AND DISEASES

Cancer stem cells as the relevant biomass for drug discovery

(2010) Raymond J Winquist et al.   CURRENT OPINION IN PHARMACOLOGY

ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy

(2010) Xi-wei Ding et al.   LIFE SCIENCES

Tranilast inhibits the growth and metastasis of mammary carcinoma

(2009) Rabindranath Chakrabarti et al.   ANTI-CANCER DRUGS

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy

(2009) Shu Zhang et al.   ENDOCRINE-RELATED CANCER

ABC Transporters, Drug Resistance, and Cancer Stem Cells

(2009) Michael Dean   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation

(2009) Julie M. Hall et al.   MOLECULAR ENDOCRINOLOGY

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

(2009) M. A. Barhoover et al.   MOLECULAR PHARMACOLOGY

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

(2009) Bin-Bing S. Zhou et al.   NATURE REVIEWS DRUG DISCOVERY

Human exposure to polyhalogenated hydrocarbons and incidence of selected malignancies – central European experience

(2009) V. BENCKO et al.   NEOPLASMA

The pleiotropy of dioxin toxicity — Xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles

(2009) Sebastian G.B. Furness et al.   PHARMACOLOGY & THERAPEUTICS

Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer

(2009) Roy Blum et al.   PLoS One

Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

(2009) Jessica Kao et al.   PLoS One

Cancer Stem Cells in Solid Tumors: An Overview

(2009) Catherine Adell O'Brien et al.   SEMINARS IN RADIATION ONCOLOGY

Breast cancer chemoresistance: Emerging importance of cancer stem cells

(2009) Suebwong Chuthapisith et al.   SURGICAL ONCOLOGY-OXFORD

Fitting a xenobiotic receptor into cell homeostasis: How the dioxin receptor interacts with TGFβ signaling

(2008) Aurea Gomez-Duran et al.   BIOCHEMICAL PHARMACOLOGY

AHR-mediated immunomodulation: The role of altered gene transcription

(2008) Nancy I. Kerkvliet   BIOCHEMICAL PHARMACOLOGY

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

(2008) Alysha K. Croker et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

(2008) Anne-Pierre Morel et al.   PLoS One

Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties

(2008) Vera Levina et al.   PLoS One

Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population

(2008) Sebastian C.J. Steiniger et al.   STEM CELLS